文献资料信息综合查询系统
筛选条件 共查询到2条结果
排序方式
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe

期刊： PHARMACEUTICAL MEDICINE, 2021; 35 (2)

Background Apixaban (ELIQUIS(R)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional ri......

Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe

期刊： PHARMACEUTICAL MEDICINE, 2021; 35 (2)

Background Apixaban (ELIQUIS(R)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional ri......

共2条页码: 1/1页15条/页